# OnCo record paper-keynote-407-j-clin-oncol-2023-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-keynote-407-j-clin-oncol-2023-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-keynote-407-j-clin-oncol-2023-update" ;
  schema:name "Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study"@en ;
  schema:description "Later report from the KEYNOTE-407 trial registered as NCT02775435, in Journal of Clinical Oncology (2023); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-keynote-407-j-clin-oncol-2023-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.22.01990>, <https://pubmed.ncbi.nlm.nih.gov/36735893/>, <https://europepmc.org/article/MED/36735893>, <https://clinicaltrials.gov/study/NCT02775435> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.22.01990> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Novello S, Kowalski DM, Luft A, et al." ;
  onco:trials <https://onco.cc/trials/keynote-407/> ;
  onco:journals <https://onco.cc/journals/jco/> .